Cargando…

Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies

Human monoclonal antibodies (mAbs) that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been isolated from convalescent individuals and developed into therapeutics for SARS-CoV-2 infection. However, therapeutic mAbs for SARS-CoV-2 have been rendered obsolet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fengwen, Jenkins, Jesse, de Carvalho, Renan V. H., Nakandakari-Higa, Sandra, Chen, Teresia, Abernathy, Morgan E., Baharani, Viren A., Nyakatura, Elisabeth K., Andrew, David, Lebedeva, Irina V., Lorenz, Ivo C., Hoffmann, H.-Heinrich, Rice, Charles M., Victora, Gabriel D., Barnes, Christopher O., Hatziioannou, Theodora, Bieniasz, Paul D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234812/ https://www.ncbi.nlm.nih.gov/pubmed/37188812 http://dx.doi.org/10.1038/s41564-023-01389-9

Ejemplares similares

Superimmunity by pan-sarbecovirus nanobodies
por: Xiang, Yufei, et al.
Publicado: (2022)

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
por: Starr, Tyler N., et al.
Publicado: (2022)

Pan-sarbecovirus mAb protects from variants
por: Flemming, Alexandra
Publicado: (2021)

The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus
por: Wells, H.L, et al.
Publicado: (2021)

The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus
por: Wells, H L, et al.
Publicado: (2021)

Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins
por: Zhang, Fengwen, et al.
Publicado: (2022)

Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins
por: Zhang, Fengwen, et al.
Publicado: (2022)

Mutation-driven parallel evolution in emergence of ACE2-utilizing sarbecoviruses
por: Gao, Bin, et al.
Publicado: (2023)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
por: Adams, Lily E., et al.
Publicado: (2023)

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2021)

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2022)

ACE2-Independent Bat Sarbecovirus Entry and Replication in Human and Bat Cells
por: Guo, Hua, et al.
Publicado: (2022)

Isolation of ACE2-dependent and -independent sarbecoviruses from Chinese horseshoe bats
por: Guo, Hua, et al.
Publicado: (2023)

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
por: Hurlburt, Nicholas K., et al.
Publicado: (2022)

Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
por: Coléon, Séverin, et al.
Publicado: (2022)

SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release
por: Zhang, Fengwen, et al.
Publicado: (2011)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
por: Witte, Leander, et al.
Publicado: (2022)

An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models
por: Yuen, Chun-Kit, et al.
Publicado: (2023)

Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
por: Chia, Wan Ni, et al.
Publicado: (2023)

An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines
por: Seifert, Stephanie N., et al.
Publicado: (2022)

Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
por: Jensen, Jaime L., et al.
Publicado: (2023)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
por: Witte, Leander, et al.
Publicado: (2023)

Isolation of Bat Sarbecoviruses, Japan
por: Murakami, Shin, et al.
Publicado: (2022)

SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity
por: Zhang, Fengwen, et al.
Publicado: (2023)

Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors
por: Tan, Chee-Wah, et al.
Publicado: (2021)

A Multitrait Locus Regulates Sarbecovirus Pathogenesis
por: Schäfer, Alexandra, et al.
Publicado: (2022)

A comprehensive dataset of animal-associated sarbecoviruses
por: Liu, Bo, et al.
Publicado: (2023)

Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses
por: Wang, Yingdan, et al.
Publicado: (2022)

Sequence determinants of human-cell entry identified in ACE2-independent bat sarbecoviruses: A combined laboratory and computational network science approach
por: Khaledian, Ehdieh, et al.
Publicado: (2022)

Unique protein features of SARS-CoV-2 relative to other Sarbecoviruses
por: Cotten, Matthew, et al.
Publicado: (2021)

Novel attempts launched toward universal Sarbecovirus vaccine
por: Li, Haoyang, et al.
Publicado: (2021)

Genomic Bootstrap Barcodes and Their Application to Study the Evolution of Sarbecoviruses
por: Hassanin, Alexandre, et al.
Publicado: (2022)

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
por: Liu, Zezhong, et al.
Publicado: (2022)

Assisted Evolution Enables HIV-1 to Overcome a High TRIM5α-Imposed Genetic Barrier to Rhesus Macaque Tropism
por: Soll, Steven J., et al.
Publicado: (2013)

Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection
por: Poston, Daniel, et al.
Publicado: (2020)

Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
por: Poston, Daniel, et al.
Publicado: (2020)

HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137
por: Zhang, Fengwen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c3s3foa606mq0bl4tmurtpnpkn